OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dupilumab: A Review of Present Indications and Off-Label Uses
Francisco J. Muñoz‐Bellido, Esther Moreno, Ignacio Dávila
Journal of Investigational Allergology and Clinical Immunology (2021) Vol. 32, Iss. 2, pp. 97-115
Open Access | Times Cited: 93
Francisco J. Muñoz‐Bellido, Esther Moreno, Ignacio Dávila
Journal of Investigational Allergology and Clinical Immunology (2021) Vol. 32, Iss. 2, pp. 97-115
Open Access | Times Cited: 93
Showing 1-25 of 93 citing articles:
Advancing the understanding of allergic contact dermatitis: from pathophysiology to novel therapeutic approaches
Marta Tramontana, Katharina Hansel, Leonardo Bianchi, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 31
Marta Tramontana, Katharina Hansel, Leonardo Bianchi, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 31
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps
Corrado Pelaia, Alida Benfante, Maria Teresa Busceti, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
Corrado Pelaia, Alida Benfante, Maria Teresa Busceti, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study
B. Molina, Roberto Padoan, Maria Letizia Urban, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 12, pp. 1587-1593
Closed Access | Times Cited: 28
B. Molina, Roberto Padoan, Maria Letizia Urban, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 12, pp. 1587-1593
Closed Access | Times Cited: 28
Therapeutic monoclonal antibodies in allergy: Targeting IgE , cytokine, and alarmin pathways
Alexander Eggel, Luke F. Pennington, Theodore S. Jardetzky
Immunological Reviews (2024)
Open Access | Times Cited: 10
Alexander Eggel, Luke F. Pennington, Theodore S. Jardetzky
Immunological Reviews (2024)
Open Access | Times Cited: 10
Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease
Dimitrios Toumpanakis, Κonstantinos Bartziokas, Agamemnon Bakakos, et al.
Pulmonary Therapy (2025)
Open Access | Times Cited: 1
Dimitrios Toumpanakis, Κonstantinos Bartziokas, Agamemnon Bakakos, et al.
Pulmonary Therapy (2025)
Open Access | Times Cited: 1
Autophagy in asthma and chronic obstructive pulmonary disease
Peter J. Barnes, Jonathan Baker, Louise Donnelly
Clinical Science (2022) Vol. 136, Iss. 10, pp. 733-746
Open Access | Times Cited: 36
Peter J. Barnes, Jonathan Baker, Louise Donnelly
Clinical Science (2022) Vol. 136, Iss. 10, pp. 733-746
Open Access | Times Cited: 36
Atopy in chronic urticaria: an important yet overlooked issue
Qiquan Chen, Xianjie Yang, Bing Ni, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Qiquan Chen, Xianjie Yang, Bing Ni, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: results of a phase 2 randomized controlled trial with an open‐label extension phase
Elke Weißhaar, Jacek C. Szepietowski, JD Bernhard, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 36, Iss. 3, pp. 453-461
Closed Access | Times Cited: 38
Elke Weißhaar, Jacek C. Szepietowski, JD Bernhard, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 36, Iss. 3, pp. 453-461
Closed Access | Times Cited: 38
Dupilumab in the treatment of genodermatosis: A systematic review
Po‐Chien Wu, Ying‐Xiu Dai, Chia‐Lun Li, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 1, pp. 7-17
Closed Access | Times Cited: 15
Po‐Chien Wu, Ying‐Xiu Dai, Chia‐Lun Li, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 1, pp. 7-17
Closed Access | Times Cited: 15
A Review of Existing and New Treatments for the Management of Hand Eczema
Jessica S. S. Ho, Sonja Molin
Journal of Cutaneous Medicine and Surgery (2023) Vol. 27, Iss. 5, pp. 493-503
Open Access | Times Cited: 14
Jessica S. S. Ho, Sonja Molin
Journal of Cutaneous Medicine and Surgery (2023) Vol. 27, Iss. 5, pp. 493-503
Open Access | Times Cited: 14
Dupilumab’s Impact on Blood Parameters in Nasal Polyposis: 18-Month Follow-Up in Real Life
Antonella Loperfido, Andrea Ciofalo, Carlo Cavaliere, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-10
Open Access | Times Cited: 13
Antonella Loperfido, Andrea Ciofalo, Carlo Cavaliere, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-10
Open Access | Times Cited: 13
Quick Treatment of Very Severe Refractory Hand and Foot Eczema with Dupilumab: A Case Report and Literature Review
Yali Li, Jialing Xiao, Yi Sun, et al.
Journal of Asthma and Allergy (2023) Vol. Volume 16, pp. 1-8
Open Access | Times Cited: 12
Yali Li, Jialing Xiao, Yi Sun, et al.
Journal of Asthma and Allergy (2023) Vol. Volume 16, pp. 1-8
Open Access | Times Cited: 12
The evolving therapeutic landscape in atopic dermatitis
Luis Angel Hernández-Zárate, Carlos Andrés Gómez-Núñez, Stefan Narváez-Labuhn, et al.
(2025) Vol. 3
Closed Access
Luis Angel Hernández-Zárate, Carlos Andrés Gómez-Núñez, Stefan Narváez-Labuhn, et al.
(2025) Vol. 3
Closed Access
Eosinophilic esophagitis in the “atopic march”: dupilumab as an “umbrella” strategy for multiple coexisting atopic diseases
Nicola Lutzu, Agnese Favale, M. Demurtas, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Nicola Lutzu, Agnese Favale, M. Demurtas, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Efficacy and Safety of Dupilumab Across Different Th2-Type-Mediated Diseases: A Real-Life Preliminary Experience
Ciro Romano, Domenico Cozzolino, Maria Elena Corona, et al.
Biologics (2025) Vol. 5, Iss. 1, pp. 3-3
Open Access
Ciro Romano, Domenico Cozzolino, Maria Elena Corona, et al.
Biologics (2025) Vol. 5, Iss. 1, pp. 3-3
Open Access
Rosacea-like skin reaction under treatment with dupilumab for atopic dermatitis
Caleb W. Grote, Franziska Zirkenbach, Josef Wagner, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access
Caleb W. Grote, Franziska Zirkenbach, Josef Wagner, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access
Small airways dysfunction in severe asthma: Current treatment approaches and future directions
Nishan Deng, Yunyan Xianyu, Yaqing Xu, et al.
Journal of the Formosan Medical Association (2025)
Open Access
Nishan Deng, Yunyan Xianyu, Yaqing Xu, et al.
Journal of the Formosan Medical Association (2025)
Open Access
A Case of Unexpected Successful Treatment of Alopecia Areata With Tralokinumab in a Patient With Atopic Dermatitis
Jacqueline Kussini, Wolfgang Pfützner, Stefan Mühlenbein
International Journal of Dermatology (2025)
Closed Access
Jacqueline Kussini, Wolfgang Pfützner, Stefan Mühlenbein
International Journal of Dermatology (2025)
Closed Access
Efficacy and Safety of Dupilumab Monotherapy in Patients With Dystrophic Epidermolysis Bullosa: A Retrospective Study of 8 Cases
Limin Dou, Fuying Chen, Wei He, et al.
The Journal of Dermatology (2025)
Closed Access
Limin Dou, Fuying Chen, Wei He, et al.
The Journal of Dermatology (2025)
Closed Access
Long-term treatment outcomes and safety of dupilumab as a therapy for bullous pemphigoid: A multicenter retrospective review
Christine Learned, Stephanie R. Cohen, Kaitlynne Cunningham, et al.
Journal of the American Academy of Dermatology (2023) Vol. 89, Iss. 2, pp. 378-382
Closed Access | Times Cited: 9
Christine Learned, Stephanie R. Cohen, Kaitlynne Cunningham, et al.
Journal of the American Academy of Dermatology (2023) Vol. 89, Iss. 2, pp. 378-382
Closed Access | Times Cited: 9
Severe hypereosinophilia in a patient treated with dupilumab and shift to mepolizumab: the importance of multidisciplinary management. A case report and literature review
Sara Munari, Giulia Ciotti, Walter Cestaro, et al.
Drugs in Context (2024) Vol. 13, pp. 1-11
Open Access | Times Cited: 3
Sara Munari, Giulia Ciotti, Walter Cestaro, et al.
Drugs in Context (2024) Vol. 13, pp. 1-11
Open Access | Times Cited: 3
Cytokines in PD-1 immune checkpoint inhibitor adverse events and implications for the treatment of uveitis
Aaron C. Brown, José Quiroz, Devayu Parikh, et al.
BMC Ophthalmology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Aaron C. Brown, José Quiroz, Devayu Parikh, et al.
BMC Ophthalmology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Insights into the Implications of Coexisting Type 2 Inflammatory Diseases
Justin P. McCormick, Jivianne Lee
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 4259-4266
Open Access | Times Cited: 22
Justin P. McCormick, Jivianne Lee
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 4259-4266
Open Access | Times Cited: 22
Aiming to IgE: Drug development in allergic diseases
Xiao-Jing Ling, Ji‐Fu Wei, Ying Zhu
International Immunopharmacology (2023) Vol. 121, pp. 110495-110495
Closed Access | Times Cited: 7
Xiao-Jing Ling, Ji‐Fu Wei, Ying Zhu
International Immunopharmacology (2023) Vol. 121, pp. 110495-110495
Closed Access | Times Cited: 7
Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
Changhua Zhu, Jie Shen Fok, Lihang Lin, et al.
JAAD Case Reports (2022) Vol. 32, pp. 109-112
Open Access | Times Cited: 11
Changhua Zhu, Jie Shen Fok, Lihang Lin, et al.
JAAD Case Reports (2022) Vol. 32, pp. 109-112
Open Access | Times Cited: 11
